These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 375485)

  • 21. Sulfadoxine-pyrimethamine, chlorproguanil-dapsone, or chloroquine for the treatment of Plasmodium vivax malaria in Afghanistan and Pakistan: a randomized controlled trial.
    Leslie T; Mayan MI; Hasan MA; Safi MH; Klinkenberg E; Whitty CJ; Rowland M
    JAMA; 2007 May; 297(20):2201-9. PubMed ID: 17519409
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparative study of malaria prophylaxis in peninsular Malaysia using chloroquine and a combination of sulphadoxine and pyrimethamine.
    Ponnampalam JT
    J Trop Med Hyg; 1978 Oct; 81(10):198-203. PubMed ID: 366165
    [No Abstract]   [Full Text] [Related]  

  • 23. [Uncomplicated malaria attack in an area with high resistance to chloroquine. 3. The use of second-choice oral drug treatment].
    Hengy C; Eberlé F; Gazin P; Kouka-Bemba D; Gelas H; Jambou R
    Bull Soc Pathol Exot; 1990; 83(1):61-5. PubMed ID: 2190706
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sequential treatment with quinine and mefloquine or quinine and pyrimethamine-sulfadoxine for falciparum malaria.
    Hall AP; Doberstyn EB; Karnchanachetanee C; Samransamruajkit S; Laixuthai B; Pearlman EJ; Lampe RM; Miller CF; Phintuyothin P
    Br Med J; 1977 Jun; 1(6077):1626-8. PubMed ID: 326337
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical efficacy of sulfadoxine-pyrimethamine in the treatment of falciparum malaria in Sabah, Malaysia.
    Tan HS; Tan PE
    Ann Acad Med Singap; 1984 Apr; 13(2):170-4. PubMed ID: 6388486
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chemosuppressive field trials in Thailand. III. The suppression of Plasmodium falciparum and Plasmodium vivax parasitemias by a sulfadoxine-pyrimethamine combination.
    Pearlman EJ; Lampe RM; Thiemanun W; Kennedy RS
    Am J Trop Med Hyg; 1977 Nov; 26(6 Pt 1):1108-15. PubMed ID: 339754
    [No Abstract]   [Full Text] [Related]  

  • 27. Falciparum malaria resistant to chloroquine and fansidar: implications for prophylaxis.
    Herzog C; Kibbler CC; Ellis CJ; Mtawali CV
    Br Med J (Clin Res Ed); 1983 Oct; 287(6397):947-8. PubMed ID: 6412900
    [No Abstract]   [Full Text] [Related]  

  • 28. Mefloquine, sulfadoxine, and pyrimethamine in the treatment of symptomatic falciparum malaria: a double-blind trial for determining the most effective dose.
    Harinasuta T; Bunnag D; Vanijanond S; Charoenlarp P; Suntharasmai P; Chitamas S; Sheth UK; Wernsdorfer WH
    Bull World Health Organ; 1987; 65(3):363-7. PubMed ID: 3311439
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fansimef [Fansidar plus mefloquine] is effective treatment for imported malaria in New Zealand.
    Ellis-Pegler RB; Beeching NJ; Eales M; Fraser AG; Wells AU
    Aust N Z J Med; 1988 Aug; 18(5):733-4. PubMed ID: 3072955
    [No Abstract]   [Full Text] [Related]  

  • 30. Falciparum malaria resistant to chloroquine and Fansidar: implications for prophylaxis.
    Eyre SJ
    Br Med J (Clin Res Ed); 1984 Feb; 288(6417):644. PubMed ID: 6421416
    [No Abstract]   [Full Text] [Related]  

  • 31. Tolerance and haematological findings with antimalarials (chloroquine and Fansidar [pyrimethamine plus sulfadoxine]) in adults and children during field trials in Nigeria.
    Ekanem OJ; Bonmarchand M
    Acta Trop; 1980 Sep; 37(3):249-52. PubMed ID: 6106362
    [No Abstract]   [Full Text] [Related]  

  • 32. [A case of malaria tropicameningoencephalitis (neuromalaria) with chloroquine and pyrimethamine/sulfadoxine resistance].
    Niklewski G; Landscheidt H; Glasner H
    Nervenarzt; 1985 Feb; 56(2):101-5. PubMed ID: 3885058
    [No Abstract]   [Full Text] [Related]  

  • 33. Falciparum malaria treated with a fixed combination of mefloquine, sulfadoxine and pyrimethamine: a field study in adults in Burma.
    Tin F; Hlaing N; Tun T; Win S; Lasserre R
    Bull World Health Organ; 1985; 63(4):727-30. PubMed ID: 2935320
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Problems with pyrimethamine/sulfadoxine malaria prophylaxis.
    Lelijveld J
    Lancet; 1982 Apr; 1(8277):915. PubMed ID: 6122136
    [No Abstract]   [Full Text] [Related]  

  • 35. Fansimef in the treatment of malaria.
    Prociv P
    Aust N Z J Med; 1989 Aug; 19(4):411. PubMed ID: 2675819
    [No Abstract]   [Full Text] [Related]  

  • 36. Comparison of mefloquine, chloroquine plus pyrimethamine-sulfadoxine (Fansidar), and chloroquine as malarial prophylaxis in eastern Thailand.
    Boudreau EF; Pang LW; Chaikummao S; Witayarut C
    Southeast Asian J Trop Med Public Health; 1991 Jun; 22(2):183-9. PubMed ID: 1948277
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The efficacy of artemether (qinghaosu) in Plasmodium falciparum and P. vivax in Burma.
    Pe Than Myint ; Tin Shwe
    Southeast Asian J Trop Med Public Health; 1986 Mar; 17(1):19-22. PubMed ID: 3526578
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chloroquine resistance in Plasmodium falciparum in KwaZulu, 1983-1988.
    Hansford CF
    S Afr Med J; 1989 Nov; 76(10):546-7. PubMed ID: 2686047
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A phase II/III double-blind, dose-finding clinical trial of a combination of mefloquine, sulfadoxine, and pyrimethamine (Fansimef) in falciparum malaria.
    de Souza JM; Sheth UK; Wernsdorfer WH; Trigg PI; Doberstyn EB
    Bull World Health Organ; 1987; 65(3):357-61. PubMed ID: 3311438
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Concurrent chloroquine- and Fansidar-resistant Plasmodium falciparum: an imported case into Zimbabwe.
    Dallas AB; Okwanga PN; Mutambu SL; Pfumojena JW
    J Trop Med Hyg; 1986 Oct; 89(5):265-8. PubMed ID: 3540319
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.